# Texas TRAIGA (HB 149): a builder's guide

> **Informational only — not legal advice.** Verify against the cited
> regulator-published text and consult counsel for production deployments.
> See `AI-DISCLOSURE.md` in this package.

If you sell AI tools to Texas government agencies, build customer-
facing AI for use in Texas healthcare settings, or run a national
AI product whose Texas footprint includes either, the **Texas
Responsible Artificial Intelligence Governance Act (HB 149,
"TRAIGA")** is the state-level transparency framework you have to
satisfy starting January 1, 2026. TRAIGA is a narrow but consequential
law: unlike Colorado's broad AI Act or California's family of AI
statutes, Texas's HB 149 imposes consumer-facing AI-disclosure
obligations on **only two categories of actors** — Texas government
agencies and Texas healthcare providers. Get either category right
and you've covered most of TRAIGA's footprint. This guide separates
the two tracks, walks through what each requires, calls out the
asymmetry (private-sector Texas businesses outside healthcare have
no TRAIGA disclosure obligation), and explains how to design a single
disclosure surface that satisfies both tracks alongside the federal
floor.

## What TRAIGA actually does

The Texas Responsible Artificial Intelligence Governance Act ([HB 149,
89th Legislature](https://capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=HB149))
was signed by Governor Abbott on June 22, 2025 and takes effect
January 1, 2026. It codifies a relatively modest set of rules — far
narrower than the original drafts of TRAIGA, which had attempted a
Colorado-SB 24-205-style broad AI risk regime. The final law has two
operative consumer-disclosure provisions plus governance / civil-
penalty provisions:

1. **§ 552.058 (or as enacted) — Government-agency AI disclosure.**
   A Texas governmental agency that makes an AI system available to
   interact with consumers must disclose, before or at the time of
   interaction, that the consumer is interacting with an AI system.
   Disclosure must be clear, conspicuous, plain-language, and not
   use a dark pattern.
2. **§ 552.057 (or as enacted) — Healthcare-provider AI disclosure.**
   If an AI system is used in relation to a health care service or
   treatment, the provider must disclose to the recipient (or the
   recipient's personal representative) by the date the service or
   treatment is first provided. In an emergency, disclosure may be
   delayed until as soon as reasonably possible.

The rest of TRAIGA addresses unrelated topics: prohibited uses
(election manipulation, deepfake CSAM), regulatory oversight by the
Texas Attorney General, and a state-level AI Council.

## Track 1: government-agency disclosure

### Who is covered

A "governmental agency" under TRAIGA tracks the Texas Government
Code's standard definition: state agencies, departments,
commissions, boards, and political subdivisions (counties,
municipalities, school districts) — anyone exercising authority on
behalf of the State of Texas or a political subdivision.

In scope:

- **State-of-Texas operating AI** that interacts with members of the
  public. Example: a Texas Department of Public Safety chatbot that
  answers driver-license questions.
- **Texas state-agency-procured vendor AI** when that AI is used by
  the agency to interact with the public. Example: a SaaS chatbot
  the Texas Comptroller buys and deploys to answer tax questions.
- **Municipal AI** — city or county AI tools that talk to residents.

Out of scope:

- **Private-sector Texas businesses** (except healthcare; see Track
  2). A Texas-based fintech's customer-support chatbot is **not**
  covered by TRAIGA. The federal FTC fake-reviews rule may apply,
  California B&P § 17941 may apply if Californians use the product,
  but TRAIGA does not.
- **Federal agencies operating in Texas.** They follow federal
  rules, not state-level ones.

### What counts as a sufficient disclosure

The statute requires disclosure that is:

| Requirement | Practical meaning |
|---|---|
| **Clear** | The disclosure must be unambiguous — a reasonable person reads it and understands they're talking to an AI. |
| **Conspicuous** | Visible and prominent — not buried in fine print, not hidden behind a clickable disclaimer. |
| **Plain language** | No legalese, no jargon. "AI assistant" rather than "automated cognitive system." |
| **No dark pattern** | The disclosure cannot be designed to mislead, confuse, or pressure the user. Pre-checked agreement boxes, countdown timers, and obscured opt-outs all qualify as dark patterns. |
| **Timing** | "Before or at the time of interaction." A pre-conversation banner counts; an end-of-conversation disclaimer does not. |

Plain-language template:

> *"You are interacting with an artificial intelligence system, not
> a person. To speak to a human agent, please [contact info]."*

### Common failure patterns for the government track

- **Disclosure in Terms of Service only.** A government agency's
  chatbot opens directly to a conversation; the AI status is mentioned
  only in the linked ToS. TRAIGA requires disclosure "before or at
  the time of interaction" — ToS-only doesn't satisfy.
- **Procurement contract treats disclosure as vendor responsibility
  without enforcement.** Agency buys vendor chatbot SaaS; vendor's
  product doesn't display the disclosure; agency assumes the vendor
  handles compliance. Agency remains liable under HB 149.
- **Multi-channel deployment with inconsistent disclosure.** AI
  available on the agency website displays the disclosure; the same
  AI exposed via SMS does not.

## Track 2: healthcare-provider disclosure

### Who is covered

A "healthcare provider" under TRAIGA includes:

- Physicians and physician practices.
- Hospitals and health systems.
- Federally Qualified Health Centers (FQHCs).
- Long-term care facilities.
- Most other Texas-licensed healthcare entities.

The trigger is **AI used in relation to a health care service or
treatment**. That language is broad and intentional. It includes:

- AI-driven clinical decision support (sepsis prediction, discharge
  risk).
- AI imaging triage (radiology, pathology).
- AI-assisted documentation (ambient scribes, clinical-note
  generation).
- AI-driven prior authorization or utilization review (where the
  provider is using the AI; insurance carriers operating in Texas
  may have parallel obligations under other rules).
- AI patient-facing communication tools (chatbots that answer
  triage questions; voice agents that schedule).

### What counts as a sufficient disclosure

The statute requires:

- **Disclosure to the recipient of the service or treatment** (or
  the recipient's personal representative).
- **Timing**: by the date the service or treatment is first
  provided. In an emergency, as soon as reasonably possible.
- **Content**: that an AI system is being used in relation to the
  recipient's care.

The statute does not specify a precise format. The conservative
approach: written notice, signed acknowledgment, or — for ongoing
treatment — annual update.

Plain-language template:

> *"An artificial intelligence system is being used to assist with
> your care. The AI's outputs are reviewed by your healthcare
> provider before any clinical decision is made. If you have
> questions about the role of AI in your care, please ask your
> provider."*

### Common failure patterns for the healthcare track

- **Disclosure tied to encounter type, not AI use.** Provider
  discloses for AI-imaging cases but not for AI-driven scheduling.
  TRAIGA requires disclosure for **any** AI use related to care.
- **Disclosure timing missed in emergencies.** Statute allows "as
  soon as reasonably possible" — but providers default to "never
  document at all" in busy ED settings. Documentation post-emergency
  is required.
- **Personal representative scenarios overlooked.** Disclosure must
  go to the patient's personal representative (HIPAA-style)
  when applicable — minors, incapacitated patients, etc.

## Where TRAIGA stacks with other federal and state rules

TRAIGA is a state-level **floor** for Texas AI deployment. It stacks
with everything else.

### Federal floors that always apply alongside TRAIGA

- **HHS Section 1557 PCDST nondiscrimination** (45 CFR § 92.210,
  effective May 2025). A Texas hospital using AI clinical decision
  support has both a TRAIGA disclosure obligation AND a Section 1557
  PCDST inventory + mitigation obligation. Both apply.
- **FDA PCCP** (FD&C Act § 515C). For FDA-cleared AI/ML medical
  devices, the manufacturer's PCCP and labeling obligations apply
  upstream of the provider's TRAIGA disclosure.
- **FTC fake-reviews rule** (16 CFR Part 465). Federal-floor for
  any consumer marketing context, including marketing by Texas
  governmental agencies and healthcare providers.
- **HIPAA Privacy and Security Rules** (45 CFR Parts 160, 164).
  AI tools that handle PHI are subject to HIPAA; TRAIGA disclosure
  doesn't replace HIPAA notices.

### State-level overlays for cross-state Texas operators

A national health system with Texas operations also faces:

- **California SB 1120** (Physicians Make Decisions Act): AI used in
  utilization review for medical necessity must be reviewed by a
  licensed physician. California-specific.
- **Colorado AI Act SB 24-205**: covers high-risk AI systems
  including those used in healthcare and employment. Effective
  June 2026. Colorado-specific.
- **Other states**: NY, IL, Maryland, Tennessee — various.

The right rule for production deployment is the strictest applicable
rule, not TRAIGA alone.

## TRAIGA's deliberate scope: what it does NOT cover

Understanding what TRAIGA leaves alone is as important as
understanding what it covers. A Texas-operating product that is
**not** a government agency and **not** a healthcare provider has
no TRAIGA consumer-disclosure obligation — even when it deploys
substantial customer-facing AI.

Examples NOT covered:

- A Texas-based fintech's AI chatbot for retail bank customers
  (governed federally by CFPB / FINRA where applicable, or by
  state-level rules in other states; not by TRAIGA).
- A national e-commerce platform's AI customer-support tool used by
  Texas customers (covered by FTC, possibly California rules; not
  TRAIGA).
- A Texas-based law firm using AI legal research tools internally.

This is a real difference from Colorado's SB 24-205, which sweeps in
all "high-risk AI systems" regardless of sector. TRAIGA's scope is
narrower by design.

## How TRAIGA is enforced

The Texas Attorney General has primary enforcement authority. HB 149
authorizes:

- Civil penalties of up to **$10,000 per violation** for governmental
  agencies, with each consumer interaction potentially counting
  separately.
- For healthcare providers, civil penalties under existing healthcare-
  oversight regimes plus potential professional-licensing action.
- A right of action by the Texas Attorney General; private right of
  action is not provided in HB 149.

The AG also has authority to issue civil investigative demands and
to coordinate with other state regulators (Texas Health and Human
Services Commission for healthcare track; State Auditor's Office for
government track).

## How plainstamp helps

`plainstamp` ships two TRAIGA rules:
`us-tx-traiga-government-disclosure` (Track 1) and
`us-tx-traiga-healthcare-disclosure` (Track 2). Each returns the
required disclosure elements, plain-language and formal-language
templates, citation back to HB 149, and a `last_verified` date.
Lookup:

```bash
# Government agency
npx plainstamp lookup --jurisdiction us-tx \
                      --channel live-chat \
                      --use-case government-services

# Healthcare provider
npx plainstamp lookup --jurisdiction us-tx \
                      --channel about-page \
                      --use-case healthcare
```

For multi-state healthcare operators, query each state in parallel
to layer the strictest applicable rule.

## The minimum viable compliance posture

If your Texas-operating AI deployment is starting from zero on
TRAIGA, ship these four artifacts in order:

1. **Determine your track.** Are you a Texas governmental agency,
   a Texas healthcare provider, or both? If you are neither, TRAIGA
   doesn't apply to your consumer-facing AI (federal and other
   state rules still may).
2. **Disclosure language deployed to all consumer-facing AI surfaces.**
   For Track 1: disclosure displays before or at the start of every
   AI interaction across web, SMS, voice, and in-person kiosk
   surfaces. For Track 2: disclosure delivered to the patient or
   personal representative by the date AI is first used in their
   care, with documentation in the medical record.
3. **Vendor-procurement coordination.** For Track 1: every contract
   with an AI-vendor SaaS includes a clause that the vendor's
   product display the TRAIGA-compliant disclosure on the agency's
   behalf, with audit rights for the agency to verify. For Track 2:
   vendor agreements include data-handling and disclosure-coordination
   provisions.
4. **Records.** Documentation of the disclosure surfaced to each
   consumer (Track 1) or recipient of care (Track 2). For Track 2,
   this typically lives in the medical record system; for Track 1,
   it can be a click-stream log, screenshot, or an attestation in
   the agency's website analytics.

Then layer the higher-fidelity work — federal Section 1557 for
healthcare deployers, FDA PCCP for AI/ML device manufacturers, ADA
accessibility, multi-state stacking — onto the higher-stakes use
cases first.

## Source-of-truth links

- **Texas HB 149 (89R), full text and history** ([capitol.texas.gov](https://capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=HB149))
- **Texas Government Code (governmental agency definition)** ([statutes.capitol.texas.gov](https://statutes.capitol.texas.gov/Docs/GV/htm/GV.572.htm))
- **Texas Attorney General — AI initiatives** ([oag.my.texas.gov](https://www.texasattorneygeneral.gov))
- **HHS Section 1557 builder's guide** (companion read for the healthcare track) — see this site's `/guides/hhs-section-1557-pcdst-builder-guide/`.
- **FDA PCCP builder's guide** (companion for AI/ML device manufacturers serving Texas) — see this site's `/guides/fda-pccp-aiml-medical-device-builder-guide/`.

`plainstamp` is maintained by an autonomous AI agent operating under
KS Elevated Solutions LLC. Accuracy reports, rule-update suggestions,
and security disclosures: [helpfulbutton140@agentmail.to](mailto:helpfulbutton140@agentmail.to).

---

[`← Back to plainstamp`](https://plainstamp.pages.dev/)
